Literature DB >> 6183196

Differential recognition of the serologically defined HLA-A2 antigen by allogeneic cytotoxic T cells. I. Population studies.

S Horai, J J van der Poel, E Goulmy.   

Abstract

Human alloimmune cytotoxic T cells, sensitized selectively against the HLA-A2 antigen, were tested on a panel of selected target cells. Five HLA-A2 positive outlier cells could be identified. These outlier cells were only weakly lysed by HLA-A2 specific CTLs, although they were serologically indistinguishable from the other HLA-A2 positive, strongly lysed target cells. Furthermore, it was found that the outlier cells were poor cold target inhibitors in contrast to the other HLA-A2 positive target cells, which showed adequate inhibition of specific lysis of HLA-A2 positive target cells. Population studies indicate that the frequency of such HLA-A2 outlier cells may be approximately 10%.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6183196     DOI: 10.1007/bf00364400

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  24 in total

1.  Cell mediated lympholysis in man. Occurrence of unexpected, HL-A (LA and FOUR) irrelevant lympholysis.

Authors:  T Kristensen; N Grunnet; F Kissmeyer-Nielsen
Journal:  Tissue Antigens       Date:  1974

2.  Cell-mediated lympholysis in HL-A identical unrelated individuals.

Authors:  M Schapira; M Jeannet
Journal:  Tissue Antigens       Date:  1974

3.  Cell-mediated lympholysis in vitro with normal lymphocytes as target: specificity and cross-reactivity of the test.

Authors:  V C Miggiano; D Bernoco; J Lightbody; G Trinchieri; R Ceppellini
Journal:  Transplant Proc       Date:  1972-06       Impact factor: 1.066

4.  Mutationally derived H-2 antigenic differences as defined by cytolytic T lymphocyte clones.

Authors:  L A Sherman
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

5.  Target antigens of cell-mediated lympholysis discrimination of HLA subtypes by cytotoxic lymphocytes.

Authors:  M A Robinson; H J Noreen; D B Amos; E J Yunis
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

6.  Cell mediated lympholysis in man. The impact of HLA-C antigens.

Authors:  N Grunnet; T Kristensen; F Kissmeyer-Nielsen
Journal:  Tissue Antigens       Date:  1976-05

7.  Virus-immune cytotoxic T cells recognize structural differences between serologically indistinguishable HLA-A2 molecules.

Authors:  W E Biddison; M S Krangel; J L Strominger; F E Ward; G M Shearer; S Shaw
Journal:  Hum Immunol       Date:  1980-10       Impact factor: 2.850

8.  Cytotoxic effector cells against HLA antigens in strong linkage disequilibrium: identification of a strong, new CML determinant.

Authors:  F T Christiansen; S J Kim; D M Silver; B Dupont
Journal:  Hum Immunol       Date:  1981-02       Impact factor: 2.850

9.  Cell-mediated lymphocytotoxicity directed against HLA-D gene products.

Authors:  D Albrechtsen; E Arnesen; E Thorsby
Journal:  Transplantation       Date:  1979-05       Impact factor: 4.939

10.  HLA-D region-associated determinants serve as targets for human cell-mediated lysis.

Authors:  C Feighery; P Stastny
Journal:  J Exp Med       Date:  1979-02-01       Impact factor: 14.307

View more
  14 in total

1.  Bovine alloreactive cytotoxic cells generated in vitro detect BoLA w6 subgroups.

Authors:  R L Spooner; E A Innes; P Millar; S P Simpson; J Webster; A J Teale
Journal:  Immunology       Date:  1987-05       Impact factor: 7.397

2.  Identification of HLA-B44 subtypes associated with extended MHC haplotypes.

Authors:  M S Kruskall; E E Eynon; Z Awdeh; C A Alper; E J Yunis
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

3.  DNA sequences of the genes that encode the CTL-defined HLA-A2 variants M7 and DK1.

Authors:  D H Mattson; D E Handy; D A Bradley; J E Coligan; E P Cowan; W E Biddison
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

4.  Interaction between des-Tyr1-gamma-endorphin and HLA class I molecules: serological detection of an HLA-A2 subtype.

Authors:  F H Claas; J J van der Poel; R Castelli-Visser; J Pool; R B Chen; K Y Xu; J J van Rood
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

5.  Alloreactivity studied with mutants of HLA-A2.

Authors:  J Santos-Aguado; M A Crimmins; S J Mentzer; S J Burakoff; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

6.  Identification of several functional subgroups of HLA-B27 by restriction of the activity of antiviral T killer lymphocytes.

Authors:  A Toubert; E Gomard; F C Grumet; B Amor; J Y Muller; J P Levy
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

7.  Analysis of the functional epitopes on different HLA-A2 molecules.

Authors:  E Goulmy; J van der Poel; M Giphart; J J van Rood
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

8.  Differential recognition of the serologically defined HLA-A2 antigen by allogeneic cytotoxic T cells. II. Definition of three HLA-A2 subtypes by CTLs.

Authors:  J J van der Poel; J Pool; E Goulmy; J J van Rood
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

9.  An HLA-A2 population variant with structural polymorphism in the alpha 3 region.

Authors:  R Castaño; A Ezquerra; N Doménech; J A López de Castro
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

10.  Definition of four HLA-A2 subtypes by CML typing and biochemical analysis.

Authors:  J J van der Poel; H Mölders; A Thompson; H L Ploegh
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.